Intralesional steroid injection versus voice therapy for the management of early vocal fold nodules in female patients: a randomized controlled trial
European Archives of Oto-Rhino-Laryngology · 2026-02 · 283 (2) · 955-967
DOI: 10.1007/s00405-025-09923-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 29.12.2025. Verfasst von Eman S Hassan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Phoniatric Unit, ENT Department, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt. Hauptthemen laut MEDLINE: Vocal Cords, Voice Training, Triamcinolone, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Assiut University.
Abstract (Originalsprache)
Purpose
While vocal fold steroid injection (VFSI) is emerging as a therapeutic approach for vocal fold nodules (VFNs), its comparative efficacy relative to standard voice therapy remains unestablished. This study aimed to evaluate and contrast treatment findings between VFSI and voice therapy for VFNs.
Methods
In a randomized controlled trial, 50 female patients with VFNs received either percutaneous intralesional triamcinolone injection or Accent method voice therapy. Serial evaluations—including videoendoscopic (nodule size, mucosal wave, glottic gap), subjective (auditory perceptual assessment, Voice Handicap Index), and objective (acoustic, aerodynamic) measures—were conducted at baseline and at 1 week and 1-, 2-, 3-, and 6-months post-treatment.
Results
Both groups demonstrated significant reductions in nodule size and improvements in mucosal wave patterns and glottic gaps over the 6 months ( p < 0.05). Most subjective and objective measures also enhanced significantly in both groups over the same study period ( p < 0.05). However, voice therapy outperformed VFSI in most parameters (videoendoscopic, subjective, and objective) by the end of the third month ( p < 0.05) and in nodule size reduction by the sixth month ( p = 0.049).
Conclusions
VFSI is a rapid and reliable therapeutic solution for VFNs with outcomes comparable to voice therapy. Long-term data, however, demonstrate voice therapy better prevents nodule recurrence. Therefore, subsequent voice therapy or repeated injections may enhance the long-term efficacy of VFSI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Phoniatric Unit, ENT Department, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt.
- Phoniatric Unit, ENT Department, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt. nada89@med.aun.edu.eg.
Förderung
- Assiut University
Zitieren
APA
Hassan, E. S., Kamel, N. A., & Mohamed, H. A. (2026). Intralesional steroid injection versus voice therapy for the management of early vocal fold nodules in female patients: a randomized controlled trial. European Archives of Oto-Rhino-Laryngology, 283(2), 955-967. https://doi.org/10.1007/s00405-025-09923-7
Vancouver
Hassan ES, Kamel NA, Mohamed HA. Intralesional steroid injection versus voice therapy for the management of early vocal fold nodules in female patients: a randomized controlled trial. European Archives of Oto-Rhino-Laryngology. 2026;283(2):955-967. doi:10.1007/s00405-025-09923-7
BibTeX
@article{Hassan2026,
author = {Hassan, Eman S and Kamel, Nada A and Mohamed, Hanan A},
title = {Intralesional steroid injection versus voice therapy for the management of early vocal fold nodules in female patients: a randomized controlled trial},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
volume = {283},
number = {2},
pages = {955--967},
doi = {10.1007/s00405-025-09923-7}
}
EUVIMED